Nobivac® L4, suspension for injection for dogs
Canine leptospirosis is caused by bacteria spread in the urine of infected animals. There are a variety of serovars that may be responsible for disease as it occurs in dogs in the UK, and Europe. Nobivac L4 extends the range covered by dog vaccination to those most commonly implicated in clinical cases throughout the UK and wider Europe.
Presentation
Colourless suspension for injection
Active ingredients
Each dose of 1 ml contains:
Inactivated Leptospira strains:
- L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000) 3550-7100 U*
- L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001) 290-1000 U*
- L. interrogans serogroup Australis serovar Bratislava (strain As-05-073) 500-1700 U*
- L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005) 650-1300 U*
* Anitgenic mass ELISA units
Target species
Dogs
Indications for use
For active immunisation of dogs against:
- L. interrogans serogroup Canicola serovar Canicola to reduce infection and urinary excretion
- L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni to reduce infection and urinary excretion
- L. interrogans serogroup Australis serovar Bratislava to reduce infection
- L. kirschneri serogroup Grippotyphosa serovar Bananal/Lianguang to reduce infection and urinary excretion
Onset of immunity: 3 weeks
Duration of immunity: 1 year
Packaging
Plastic boxes of 10 and 50 single dose vials
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: October 2023